vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $27.6M, roughly 1.6× Maison Solutions Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -19.9%, a 2.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -10.9%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 42.5%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
ABCL vs MSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $27.6M |
| Net Profit | $-8.9M | $-5.0M |
| Gross Margin | — | 23.4% |
| Operating Margin | -63.7% | -4.9% |
| Net Margin | -19.9% | -18.0% |
| Revenue YoY | 788.4% | -10.9% |
| Net Profit YoY | 73.9% | -1840.5% |
| EPS (diluted) | $-0.03 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $27.6M | ||
| Q3 25 | $9.0M | $27.2M | ||
| Q2 25 | $17.1M | $34.4M | ||
| Q1 25 | $4.2M | $32.3M | ||
| Q4 24 | $5.0M | $29.4M | ||
| Q3 24 | $6.5M | $28.2M | ||
| Q2 24 | $7.3M | $16.9M | ||
| Q1 24 | $10.0M | $13.6M |
| Q4 25 | $-8.9M | $-5.0M | ||
| Q3 25 | $-57.1M | $-1.5M | ||
| Q2 25 | $-34.7M | $-287.4K | ||
| Q1 25 | $-45.6M | $1.0M | ||
| Q4 24 | — | $-256.0K | ||
| Q3 24 | $-51.1M | $700.9K | ||
| Q2 24 | $-36.9M | $-2.8M | ||
| Q1 24 | $-40.6M | $-549.0K |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 21.8% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 23.4% |
| Q4 25 | -63.7% | -4.9% | ||
| Q3 25 | -851.8% | 0.7% | ||
| Q2 25 | -290.2% | -15.9% | ||
| Q1 25 | -1479.6% | 3.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | -1439.4% | 7.3% | ||
| Q2 24 | -1276.2% | -14.4% | ||
| Q1 24 | -551.5% | -2.3% |
| Q4 25 | -19.9% | -18.0% | ||
| Q3 25 | -637.8% | -5.7% | ||
| Q2 25 | -203.3% | -0.8% | ||
| Q1 25 | -1077.2% | 3.1% | ||
| Q4 24 | — | -0.9% | ||
| Q3 24 | -785.4% | 2.5% | ||
| Q2 24 | -504.3% | -16.4% | ||
| Q1 24 | -408.0% | -4.0% |
| Q4 25 | $-0.03 | $-0.23 | ||
| Q3 25 | $-0.19 | $-0.08 | ||
| Q2 25 | $-0.12 | $-0.02 | ||
| Q1 25 | $-0.15 | $0.06 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-0.17 | $0.04 | ||
| Q2 24 | $-0.13 | $-0.16 | ||
| Q1 24 | $-0.14 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $966.9M | $11.6M |
| Total Assets | $1.4B | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | $1.1M | ||
| Q2 25 | $92.4M | $775.4K | ||
| Q1 25 | $159.3M | $445.4K | ||
| Q4 24 | $156.3M | $355.7K | ||
| Q3 24 | $126.6M | $588.9K | ||
| Q2 24 | $148.3M | $2.1M | ||
| Q1 24 | $123.6M | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $966.9M | $11.6M | ||
| Q3 25 | $964.0M | $10.1M | ||
| Q2 25 | $1.0B | $11.7M | ||
| Q1 25 | $1.0B | $12.0M | ||
| Q4 24 | $1.1B | $10.9M | ||
| Q3 24 | $1.1B | $11.2M | ||
| Q2 24 | $1.1B | $10.5M | ||
| Q1 24 | $1.1B | $13.3M |
| Q4 25 | $1.4B | $75.4M | ||
| Q3 25 | $1.4B | $73.3M | ||
| Q2 25 | $1.4B | $77.4M | ||
| Q1 25 | $1.3B | $82.7M | ||
| Q4 24 | $1.4B | $82.7M | ||
| Q3 24 | $1.4B | $82.1M | ||
| Q2 24 | $1.4B | $82.4M | ||
| Q1 24 | $1.5B | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-1.7M |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-1.7M | ||
| Q3 25 | $-52.6M | $1.1M | ||
| Q2 25 | $-32.4M | $-1.6M | ||
| Q1 25 | $-11.6M | $1.7M | ||
| Q4 24 | $-108.6M | $1.1M | ||
| Q3 24 | $-28.9M | $3.6M | ||
| Q2 24 | $-30.0M | $-2.6M | ||
| Q1 24 | $-41.7M | $-1.4M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | — | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | — | ||
| Q3 24 | $-47.4M | — | ||
| Q2 24 | $-50.1M | — | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | — | ||
| Q2 25 | -267.9% | — | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | — | ||
| Q3 24 | -728.4% | — | ||
| Q2 24 | -683.8% | — | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | — | ||
| Q2 25 | 78.2% | — | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | — | ||
| Q3 24 | 284.6% | — | ||
| Q2 24 | 274.6% | — | ||
| Q1 24 | 242.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
